## Page 1

Journal of Ethnopharmacology 223 (2018) 135–141
ContentslistsavailableatScienceDirect
Journal of Ethnopharmacology
ELSEVIER journal homepage: www.elsevier.com/locate/jethpharm
ff ®
E ect of Zembrin and four of its alkaloid constituents on electric
excitability of the rat hippocampus
Wilfried Dimpfela,⁎ , Richard Franklinb, Nigel Gerickec, Leonie Schombertd
aJustus-Liebig-University,Giessen,Germany
bHG&HPharmaceuticals(Pty)Ltd.,Bryanston,SouthAfrica
c5LoquatWalk,capeTown,SouthAfrica
dNeuroCodeAG,Wetzlar,Germany
ARTICLE INFO SUMMARY
Keywords: Ethnopharmacologicalrelevance: Sceletiumtortuosum(Mesembryanthemaceae),asucculentplantindigenousto
Reversepharmacology SouthAfrica.isconsumedintheformofteas,decoctionsandtincturesandissometimessmokedandusedas
Sceletiumtortuosum snuff.Inrecentyears,Sceletiumhasreceivedagreatdealofcommercialinterestforrelievingstressinhealthy
Zembrin® people,andfortreatingabroadrangeofpsychological,psychiatricandinflammatoryconditions.
Sceletiumalkaloids Materialandmethods: Thewholeextract(Zembrin®)wastestedexvivointhehippocampusslicepreparation
Rat after oneweekofdailyoral administration of5and10mg/kg. Fouralkaloids–mesembrine,mesembranol,
Hippocampusslice
mesembrenolandmesembrenone–weretesteddirectlyinvitro.
Populationspike
AMPAreceptor
Allfourwerealsotestedinthepresenceofdifferentglutamatereceptoragonists.
Epilepsy Results: Zembrin®exvivoaswellasallalkaloidsinvitroattenuatedtheamplitudeofthepopulationspikeduring
electric stimulation as single shock as well as theta burst stimulation. Only Mesembranol and Mesembrenol
havingahydroxylgroupatpositionC6insteadofcarbonylgroupasinmesembrineandmesembrenoneactedby
attenuationofAMPAreceptormediatedtransmissionasdocumentedforthewholeextract.
Discussion: ThecurrentexperimentalseriesrevealedanewphysiologicaleffectofZembrin®ontheelectricac-
tivityofthehippocampus.AttenuationofAMPAmediatedtransmissionhasbeenrelatedtosuccessfuladjunctive
treatmentofepilepticpatients.Administereddosesof5and10mg/kgareinlinewithadosageof50mg/subject
astestedclinically.
Conclusion: WehavediscoveredanewstructureactivityrelationshipforSceletiumalkaloids.Sinceattenuationof
AMPA mediated transmission has been related to successful adjunctive treatment of epileptic patients),
Mesembrenol andMesembranolmayserveasnewchemicalleadsforthedevelopmentofnewdrugsforthe
treatmentofepilepsy.
1. Introduction indigenoustoSouthAfrica.Traditionallydriedplantmaterial(typically
aerial parts; leaves and twigs) is chewed and the resulting saliva and
In 2015 half the Nobel Prize for physiology or medicine was plantjuicesswallowed;itisalsoconsumedintheformofteas,decoc-
awarded to Youyou Tu for her discovery concerning a novel therapy tions and tinctures and is sometimes smoked and used as snuff.
againstMalaria.Themethodologyshewasusingisknownas“Reverse Hartwich and Zwicky (1914) conclude their scientific communication
Pharmacology”(Willcox etal., 2011). Thismeansthat research starts on Sceletium expansum and Sceletium tortuosum by stating that the in-
with a bioactive plant-derived preparation and its clinical character- digenouspeopleundoubtedlyusedtheplantmoreforenjoymentthan
ization. Next, active ingredients are isolated and tested pre-clinically. asamedicine.AlthoughSceletiumismostcommonlychewed,itisalso
Modification oftheirchemicalformulaisperformedtooptimizetheir usedasatea(Jacobsen,1960;Smithetal.,1996;VanWykandWink,
action, anda new molecular template is obtained for development of 2004),takenasatincture(Pappe,1868).
newdrugstotreatparticulardiseases. In recent years, Sceletium has received a great deal of commercial
Theplant,whichwaschosenbyusforthisexperimentalserieswas interestforrelievingstressinhealthypeople,andfortreatingabroad
Sceletium tortuosum (Mesembryanthemaceae), a succulent plant range of psychological, psychiatric and inflammatory conditions
⁎Correspondingauthor.
E-mailaddress:Wilfried.Dimpfel@pharma.med.uni-gissen.de(W.Dimpfel).
https://doi.org/10.1016/j.jep.2018.05.010
Received19March2018;Accepted10May2018
Available online 22 May 2018
0378-8741/ © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).

## Page 2

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
(Gericke, 2001). A proprietary selected standardized extract has been investigation is given with respect to ionotrophic or metabotrophic
commercializedunderthenameofZembrin®.Sceletiumhasbeenusedas glutamatereceptors.
asimplemasticatory,forthereliefofthirstandhunger,tocombatfa- Hippocampus slices were obtained from 19 adult male Sprague-
tigue,asmedicines,andforsocialandspiritualpurposesbySanhunter- Dawlayrats(CharlesRiverWiga,Sulzbach,Germany).Ratswerekept
gatherers (historically referred to as Bushmen) and Khoi pastoralists underareversedday/night cyclefor2weekspriortothestartofthe
(historicallyreferredtoasHottentots)formillenniabeforetheearliest experiments to allow for the recording of in vitro activity from slices
written reports of the uses of these plants by European explorers and duringtheactivephaseoftheircircadianrhythm(Dimpfeletal.,1994).
settlers (Gericke and Viljoen, 2008). In 2009, the South African com- Preparation of the slices was performed exactly as reported earlier
pany HG&H Pharmaceuticals Pty Ltd. was granted the country's first (Dimpfel andHoffmann, 2011). In short:animals wereexsanguinated
integrated export and bioprospecting permit, allowing it to research, under ether anaesthesia, the brain was removed in total and the hip-
developandexportthefirststandardizedextractofSceletiumtortuosum pocampal formation was isolated under microstereoscopic sight. The
under the trade mark Zembrin® (Patnala and Kanfer, 2009), whereby midsection of the hippocampus was fixed to the table of a vibrating
royalties from sales of Zembrin® are paid to the South African San microtome(RhemaLabortechnik,Hofheim,Germany)usingacyanoa-
Council.Zembrin®hasbeentestedclinicallyafteracuteandrepetitive crylateadhesive, submerged inchilled bicarbonate-bufferedsaline ar-
intake using a combination of psychometry and quantitative EEG. tificial cerebrospinal fluid (ACSF): NaCl: 124mM, KCl: 5mM, CaCl2:
Zembrin®inducedapositiveeffectontheelectricalactivityofthebrain 2mM,MgSO4:2mM,NaHCO3:26mM,glucose:10mM,andcutinto
duringcognitiveprocessingafterintakeofasingledosageof50mg.In slicesof400mmthickness.Allsliceswerepre-incubatedforatleast1h
addition, alpha1 and alpha2 spectral power in the frontal brain was in Carbogen saturated ACSF (pH 7.4) in a pre-chamber before use
increasedduringseveralchallengesincludingbrainteasing,arithmetic (Dimpfeletal.,1991).
calculations and performance of a memory test. Increases of spectral Duringtheexperimentthesliceswereheldandtreatedinaspecial
alpha1powerindicateagreaterdegreeofcalmnessandmayrepresent superfusionchamber(ListElectronics,Darmstadt,Germany)according
decreaseddepressivesymptoms,whileincreasesinalpha2waveshave to Haas et al. (1979), at 35°C (Schiff and Somjen, 1985). The pre-
been relatedto memory (Dimpfelet al.,2016a, 2016b). Theseresults paration was superfused with ACSF at 180–230ml/h. Electrical sti-
werereproducedafterrepetitivedosing.Aftersixweeksalsoareduc- mulation(200µAconstantcurrentpulsesof200µspulsewidth)ofthe
tion of the anxiety questionnaire was documented. Discriminant ana- SchafferCollateralswithintheCA2areaandrecordingofextracellular
lysisrevealedaprojectionofZembrin®dataintothevicinityofanother field potentials from the pyramidal cell layer of CA1 (Dimpfel et al.,
calming preparation and a Ginkgo-Ginseng mixture (Dimpfel et al., 1991). Measurements were performed at 10min intervals to avoid
2017). Following this clinical characterization we went to active in- potentiation mechanisms. Four stimulations – each 20s apart – were
gredientsaccordingto“reversepharmacology”. averagedforeachtimepoint.Afterobtainingthreestableresponsesto
Sceletiumtortuosumisknowntocontainseveralalkaloidswitha3a- single stimuli (SS) long-term potentiation was induced by applying a
aryl-cis-octahydroindole skeleton, among them Mesembranol, thetabursttypepattern(TBS).Themeanamplitudeofthreesignalswas
Mesembrine, Mesembrenol and Mesembrenone (Harvey et al., 2011). averaged to give the mean of absolute voltage values (Microvolt) ±
The total content and relative contribution of Mesembrenol, Me- standarderrorofthemeanforfourslicesrepresentingoneoftheex-
sembrineandMesembrenonecanbeusedasmarkercompoundsforthe perimentalconditions.Foursliceswereusedfrom1ratperdaytaken
quality control of S. tortuosum raw materials, extracts and finished onedayafterthedailyadministrationbygavageof5mg/kgor10mg/
products (Shikanga et al., 2012). Rapid isolation ofthese alkaloids in kg Zembrin® or vehicle for one week. These doses were selected ac-
high yields using all-liquid technique of high-speed countercurrent cording to their efficacy in an earlier experimental series (Dimpfel
chromatography has been reported (Shikanga et al., 2011). The total et al., 2016a, 2016b). Additionally, slices from pre-treated rats (Zem-
yieldofalkaloidsisrelativelylow(0.05–2.3%ofdryweight)(Gericke, brin®orcontrol)weretestedinthepresenceofdifferentconcentrations
2002).Thepresentinvestigationaimedatacomparisonoftheeffectof ofglutamatereceptoragonistslistedinTable1.
these isolated four alkaloids with the effect of the proprietary extract Finally, 4 isolated pure alkaloids contained in Zembrin® extract
Zembrin®inthehippocampusslicemodel. (Mesembrenone, Mesembrenol, Mesembrine and Mesembranol) were
The hippocampal slice preparation is a validated model for direct testeddirectlyinthehippocampusslicepreparation,eachattwocon-
analysisofinteractionofsubstanceswithlivingneuronaltissue(Lynch centrations.(Fig.1)
andSchubert,1980;Dingledine,1984).Duetothepreservationofthe
threedimensionalstructureofthehippocampaltissue,substanceeffects 3. Results
ontheexcitabilityofpyramidalcellscanbestudiedinauniquemanner.
3.1. Populationspikeamplitudeafterpre-treatmentwithPlaceboor
2. Materialandmethods Zembrin®
Stimulation of Schaffer Collaterals leads to release of glutamate Ratsweretreateddailyforoneweekwith5mg/kgor10mg/kgof
resultinginexcitationofthepostsynapticpyramidalcells.Theresultof Zembrin® or control. Changes of the excitability of the hippocampus
theelectricstimulationcanberecordedasaso-calledpopulationspike wereexaminedthenextdaybyusinginvitroslices.Electricstimulation
(pop-spike).Theamplitudeoftheresultingpopulationspikerepresents oftheSchaffercollaterals resultedinresponsesofthepyramidal cells
the number of recruited pyramidal cells. The model of hippocampal recorded as so-called population spikes. Amplitudes up to 4mV were
pyramidalcellactivityreflectstheeffectsofphysiologicalinterventions recorded under different experimental conditions representing the
by an increase or decrease of the amplitude of the population spike. numberofrecruitedpyramidalcells.Slicesfromanimalspre-treatedfor
However, this model can also be used under so-called ex vivo condi- oneweekdailywith5mg/kgofZembrin®showedalowerexcitability,
tions.Inthiscase,thepreparationisadministereddailyforaweekand specifically observed in population spike amplitudes achieved after
thehippocampusistakenoutthenextdayforinvitrocharacterization singlestimuliaswellasafterthetaburststimulation.Amplitudeswere
of the sensitivity of the intra-hippocampal pathway to electric stimu- significantlylowerthanundercontrolconditions.Detailsaregivenin
lation.Withinasecondstep,themechanismofactionofthepreparation Fig.2.
under investigation can be approached by testing its action in the
presence of several receptor agonists or antagonists of glutamatergic 3.2. NMDAreceptormodulationbytransACBD
transmission.Ifsuchaselectivecompoundfailstoexertitsusualaction,
a clue to the mechanism of action of the preparation under TheneuronalcommunicationbetweentheSchaffercollateralsand
136

## Page 3

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
Table1
Listingofingredientsusedduringtheexperimentalseries.
Testitems Charge from
Zembrin® Ch.-B.:SCE0415–2015 HG&HPharmaceuticalsLtd.
Mesembrenone HG&HPharmaceuticalsLtd.
Mesembrenol HG&HPharmaceuticalsLtd.
Mesembrine HG&HPharmaceuticalsLtd.
Mesembranol HG&HPharmaceuticalsLtd.
Placebo(Control) Charge38837487 CarlRothGmbH&Co.
1%Glucose
(S)-(-)-5-Fluorowillardine Batchno.:9A/36714 BIOTRENDChemikalienGmbH.
Trans-ACBD Batchno.:0048BN/01 BIOTRENDChemikalienGmbH.
(±)trans-ACPD Batchno.:0053bn/01 BIOTRENDChemikalienGmbH.
O-Phospho-L-Serin Batchno.:0400BN701 BIOTRENDChemikalienGmbH.
pyramidal cells takes place by use of glutamate as neurotransmitter. Amplitude
However, different glutamate receptors are involved in this commu- [mV] -a-Control •Zembrln 5mg nZembrin 10 mg
4
nication pathway representing different functional aspects. The first
3,5
receptortobelookedatwastheNMDA(N-methyl-D-asparticacid)re-
ceptor.InordertotestapossibleinterferenceofZembrin®withNMDA 3
receptoractivatedsignalchanges,theglutamatergicneurotransmission
wastestedinthepresenceoftransACBD,averypotentandselective
NMDAreceptoragonist.Inthepresenceof0.05µMtransACBDslices
from animals pretreated with 5mg/kg of Zembrin® for one week,
showed slight but statistically significant decreases of the signal am-
plitudes in comparison to untreated slices as documented in Fig. 3.
TransACBDwasnotfullyactiveindicatingaslighteffectofZembrin® 10 20 30 40 50 60 70 80 90 100 110 120
on NMDA receptor controlled transmission in the presence of single Fig.2.DosedependenteffectsofZembrin®onpyramidalcellactivityinterms
shockstimulation. ofchangesofpopulationspikeamplitudes(asvoltageontheordinate).Results
obtainedafterperformanceofsinglestimuli(10–80min)orafterburststimuli
(90–120min).Dataaregivenasmean±S.E.M.ofn=12slicesfrom3ani-
3.3. AMPAreceptormodulationby(S)-(-)-5-Fluorowillardine mals/group.
The second glutamate receptor to be looked atwas the AMPA (α- 3.4. MetabotropicGlutamateGroupI/IIreceptormodulationby(±)trans
amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) receptor. In ACPD
order to test a possible interference of Zembrin® with AMPA receptor
activated signal changes, the glutamatergic neurotransmission was Thethirdglutamatereceptortobelookedatwasthemetabotropic
tested in the presence of(S)-(-)-5-Fluorowillardine, a very potent and groupI/IIreceptor.InordertotestapossibleinterferenceofZembrin®
selective competitive AMPA receptor agonist. In the presence of withmetabotropicglutamatereceptoractivatedsignalchanges,gluta-
0.10µM(S)-(-)-5-Fluorowillardineresponsesmatchedcompletelythose matergicneurotransmissionwasmodulatedby(±)transACPD,avery
asobtainedinslicesfromanimalspretreatedforoneweekwith5mg/ potent and selective metabotropic glutamate receptor I/II agonist. In
kgofZembrin®.TheAMPAreceptoragonistwasnotabletoexertits
thepresenceof0.025µM(±)transACPDnodifferencesofthesignal
action in slices from Zembrin® pre-treated animals. Data are docu- amplitudes in comparison to untreated slices were measured in slices
mented in Fig. 4. Thus, a strong interaction of Zembrin® with AMPA from animals treated with 5mg/kg of Zembrin® for one week as
receptormediatedneuronaltransmissionmustbeassumed. documentedinFig.5.TransACPDwasfullyactivegivingnohintsfor
aninteractionofZembrin®withthisreceptor.
Mesembrenone Mesembrenol Mesembrine Mesembranol
Fig.1.ChemicalformulasofZembrin®alkaloids.
137

## Page 4

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
Amplitude Amplitude
[mV] otrans ACBD •Pretreatment Zembrin 5 mg/kg [mV] oO-Phospho-L-Serine •Pret. Zembrin 5 mg/kg
4 4
3,5 3,5
3 3
2,5 2,5
2 2
1,5 1,5
0,5 0,5
Tlme[mlnJ
0
10 20 30 40 50 60 70 80 90 100 110 120 10 20 30 40 50 60 70 80 90 100 110 120
Fig.3.EffectsoftransACBDonpyramidalcellactivityinvitro(darkline,re- Fig.6.EffectsofO-Phospho-L-Serine(darkline,referencedatafromanearlier
ferencedatafromanearlierexperimentalseries)andinslicesfromratspre-
experimentalseries)invitroanditsfulleffectonpyramidalcellactivityinslices
treatedwith5mg/kgofZembrin®.Resultsfromsingleslicesasobtainedafter fromratspre-treatedwith5mg/kgofZembrin®.Resultsfromsingleslicesas
single stimuli (60–80min on the abscissa) or after burst stimuli (TBS, obtainedaftersinglestimuli(60–80min)orafterburststimuli(TBS).Dataare
100–120min). Data are given as mean±S.E.M. Amplitude of the signal is given as mean±S.E.M. Amplitude of the signal is given as voltage in mV
givenasvoltageinmV(ordinate). (ordinate).
Amplitude
L-Serineinslicesfromanimalspretreatedwith5mg/kgofZembrin®for
[mV] oFluorowlllardlne •Pretreatment Zembrln 5 mg/kg one week no differences of the signal amplitudes in comparison to
4
untreatedslicesweremeasuredasdocumentedinFig.6.O-Phospho-L-
3,5
Serine was fully active giving no hints for an interaction of Zembrin®
3
withthisreceptor.
2,5
2
3.6. OverviewontheeffectofZembrin®onglutamatergicreceptor
1,5
modulation
0,5 Intra-hippocampalcommunicationismodulatedbydifferentgluta-
0 +--~-~------~-~-~-~-~_ _T_ l_m_e----a[.m_ln~Jc... mate receptors, which either are related directly to ion channels
10 20 30 40 50 80 70 80 90 100 110 120
(NMDA and AMPA) or act via metabotropic changes. Highly potent
Fig.4.Effectof(s)-(-)-5-Fluorowillardine(darkline),referencedatafroman agonistsatthesereceptorsinduceasignificantincreaseofthepopula-
earlier experimental series) in vitro and lack of its effect on pyramidal cell
tionspikeamplitudesinthepresenceofsingleshockstimuliandduring
activityinslicesfromratspre-treatedwith5mg/kgofZembrin®.Resultsfrom
theta burst stimulation as documented in Figs. 7 and 8, respectively
single slicesasobtainedaftersinglestimuli (60–80minonabscissa)orafter
burst stimuli (TBS) (100–120min). Data are given as mean±S.E.M. (data from an earlier experimental series for comparison, marked as
black columns). The low dosage of Zembrin® - administered for one
AmplitudeofthesignalisgivenasvoltageinmV(ordinate).
week - significantly reduced the amplitude of the population spike
amplitudeincomparisontoControl (ACSF).Fluorowillardine, specifi-
Amplitude
[mV] otransACPD •Pretreatment Zembrin 5 mg/kg callyactingontheAMPAreceptorwasnotableanymoretoinducean
4
increaseofthepopulationspikeinZembrin®pre-treatedanimals.Trans
3,5
ACPDwasonlypartiallyactiveinZembrin®pre-treatedanimals.Thus,
3
Zembrin®obviouslyinteractedonlywithionotropicreceptormediated
2,5 electric activity. An overview is given in Fig. 7 for data obtained by
singleshockstimulationandinFig.8forthetaburststimulation.
2
1,5
Amplitude Single Shock Stimulation
[mV)
4
0,5
0 +--~-----~~-~-~-~-~-~--T~lm_e_[=-m,_ln~]- 3,5
10 20 30 40 so 60 70 80 90 100 110 120 3
Fig.5.Effectsof(±)transACPD(darkline,referencedatafromanearlier 2,5
experimentalseries)invitroanditsfulleffectonpyramidalcellactivityinslices
2
fromratspre-treatedwith5mg/kgofZembrin®.Resultsfromsingleslicesas
obtainedaftersinglestimuli(60–80minonabscissa)orafterburststimuli(TBS) 1,5
(100–120min).Dataare given asmean±S.E.M.Amplitude ofthe signalis
givenasvoltageinmV(ordinate).
0,5
0
3.5. MetabotropicGlutamateGroupIIIreceptormodulationbyO-Phospho- ACSF Fluorowillardlne trana-ACBD trans ACPD 0-Pho.-L-Serin
0.10 pM 0.05 pM 0.025 pM 0.05 pM
L-Serine
■ Alone ■ Pretreatment Zembrtn® 5 mg/kg
Fig.7.Effectsof5mg/kgofZembrin®inthepresenceofglutamatereceptor
Thefourthglutamatereceptortobelookedatwasthemetabotropic
agonists(x-axis).Resultsfromslicesasobtainedaftersinglestimuli.Dataare
glutamategroupIIIreceptor.Inordertotestapossibleinterferenceof
givenasmean±S.E.M.AmplitudeofthesignalisgivenasvoltageinmV(y-
both drugs with metabotropic glutamate receptor activated signal
axis). Dark graphs represent the action of glutamate receptor agonists alone
changes,glutamatergicneurotransmissionwastestedinthepresenceof (reference data from an earlier experimental series), grey graphs show the
O-Phospho-L-Serine, a very potent and selective metabotropic gluta- populationspikeamplitudesmeasuredinslicesfromanimalspre-treatedwith
matereceptorGroupIIIagonist.Inthepresenceof0.05µMO-Phospho- 5mg/kgZembrin®.Statisticalsignificanceofp<0.01ismarkedbystars.
138

## Page 5

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
Amplltude Theta Burst Stimulation Amplitude Theta Burst Stimulation
[mV] [mV]
4 4
3,5 3,5
3 3
2,5 2,5 ..-i-. ~I--
r~
*
1,5 1,5 * ~--- * r * ~
' * I
I *
0,5 0,5 '
0
ACSF Fluorowlllardlne trans-ACBD transACPD 0-Pho.-L-Serln ACS F Mesembrenone Mesembrenol Mesembrlne Mesembranol
0.10 pM 0.05 pM 0.025 pM 0.05 pM 17.14 / 34.80 17.29 / 34.58 3.46 / 8.65 17.16 / 34.32
nmol nmol nmol nmol
■ Alone ■ Pretreatment Zembrln® 5 mg/kg
Fig.8.Effectsof5mg/kgofZembrin®inthepresenceofglutamatereceptor
b
F
r
ig
o
.
sp
1
in
0
a
.
l
A
fl
m
u
p
id
lit
(
u
A
d
C
e
SF
o
)
f
o
p
r
o
t
p
w
u
o
lat
d
io
iff
n
er
s
e
p
n
i
t
ke
co
i
n
n
ce
t
n
h
t
e
ra
p
ti
r
o
e
n
s
s
en
o
c
f
e
Z
o
em
f
b
a
r
r
i
t
n
ifi
®
c
a
ia
lk
l
a
c
lo
e
i
r
d
e
s
-
agonists(x-axis).Resultsfromslicesasobtainedduringthetaburststimulation.
duringthetaburststimulation.Statisticalsignificanceofp<0.01ismarkedby
Dataaregivenasmean±S.E.M.Amplitudeofthesignalisgivenasvoltagein
stars.
mV(y-axis).Darkgraphsrepresenttheactionofglutamatereceptoragonists
alone(referencedatafromanearlierexperimentalseries),greygraphsshowthe
populationspikeamplitudesmeasuredinslicesfromanimalspre-treatedwith Amplitude
5mg/kgZembrin®.Statisticalsignificanceofp<0.01ismarkedbystars.
4
[ mV] ■ SS TBS
3,5
3.7. EffectofZembrin®alkaloidsonpopulationspikeamplitudesinvitro
2,5
AfterestablishingthephysiologicaleffectofZembrin®onglutama-
tergic AMPA receptor mediated communication the question arose if 1,5
anyoffouralkaloidconstituentscontainedinZembrin®wouldactina
similarmanner.Testingeachofthealkaloids,namelyMesembrenone, 0,5
Mesembrenol, Mesembrine and Mesembranol in the presence of two
concentrationsinthenanomolarrangerevealedthatallofthemwere Fluorowlllardlne Fluorowlllardlne Fluorowlllardlne Fluorowlllardlne Fluorowlllardlne
~~ ~~ ~~ ~~ ~~
abletoattenuatethepopulationspikeamplitudetoasignificantdegree. +M
0
e
.
s
0
e
3
m
5
b
p
r
M
an ol +M
0
•
.
-
03
m
5
b
p
r
M
en ol +M
0
e
.0
s
1
e
0
m
p
b
M
rln e +Me
0
s
.
e
0
m
35
b r
p
e
M
n one
However,MesembrenolandMesembranolinducedastrongerattenua-
Fig. 11.Amplitude of population spike in the presence of Fluorowillardine
tion in comparison to Mesembrine and Mesembrenone. Please note,
alone(referencedatafromanearlierexperimentalseries)ortogetherwiththe
thatMesembrinewastestedatlowerconcentrationsexertingasimilar fourZembrin®alkaloids.Meanvaluesof3slicesaredepictedforeachrecording
extentofattenuationat8.65nMastheotheralkaloidsatabout17nM. condition. Statistical significance between Fluorowillardine alone and the
Dataobtainedundertheconditionofsingleshockstimuliarepresented presence of the alkaloids is documented by stars. **=p<0.05;
inFig.9,andundertheconditionofthetaburststimuliinFig.10. ***=p<0.01.
In order to find out if any of the four alkaloids interact with the
glutamatergic AMPA receptor, the AMPA receptor agonist
4. Discussion
Fluorowillardine was tested in the presence of the alkaloids. In the
presence of Mesembrine and Mesembrenone, Fluorowillardine devel- Thecurrentexperimentalseriesrevealedanewphysiologicaleffect
opedanearlyfullaction,whereasinthepresenceofMesembrenolor ofZembrin®ontheelectricactivityofthehippocampus.Theexcitability
Mesembranol its action was strongly attenuated pointing to an in- of the intra-hippocampal electric circuit between the Schaffer col-
volvement of the AMPA receptor mediated transmission as the phy-
laterals and the pyramidal cells was attenuated in a dose dependent
siological mechanism of its action under both recording conditions. mannerbyrepetitivegavageadministrationofZembrin®.Singledoses
DataaregiveninFig.11. of 5 and 10mg/kg orally have been found to significantly reduce
spectral power in four brain regions of freely moving rats (Dimpfel
etal.,2016a).Withrespecttodosageourexperienceisthatwehaveto
administer5-maximum10timeshigherdosagesinratsincomparison
Amplitude Single Shock Stimulation tohumansonakg-base(seealsoShannonetal.,2007).Thatmeansthat
[m 4 V] 5mg/kginratscorrespond to0.5–1mg/kginhumans.Itcorresponds
welltothe50mg,whichwehaveadministeredinourclinicalstudies.
3,5
These doses of 5 and 10mg/kg of Zembrin® - now administered re-
3 petitivelydailyduringoneweekinrats-obviouslydown-regulatedthe
2,5 excitabilityoftheintra-hippocampalneurotransmission.SinceSchaffer
Collaterals (location of the electric stimulation) and pyramidal cells
2
(location of recording) are connected by synapses using glutamate as
1,5
transmitter,weinterrogatedwhichofthedifferentglutamatereceptors
* * * * * * might be involved. Therefore, the effect of Zembrin® was challenged
0,5 I I using 4 specific agonists given in vitro. Only the two ionotrophic re-
ceptor mediated transmissions seemed to be involved. Mainly AMPA
0 +--'--A::-:C~S"F"~ -----M,"e'cs'"e'-m~b-re_n_o_ne~Mce-.s_-em-'cb-r_e_n~o,~ M=e"s_e,m.'--cb-r~ln-e~ M~e..1s.e.,m.Lb_ra_n_o~,
17.14 / 34.80 17.29134.58 3.46 / 8.65 17,16134.32 receptormediatedtransmissionwasattenuated,butclearlylessNMDA
nmol nmol nmol nmol
receptor mediatedtransmission wasalso recognizedto be responsible
Fig.9.Amplitudeofpopulationspikeinthepresenceofartificialcerebrospinal
fortheattenuation ofthepopulation spikeamplitudesinduced byre-
fluid(ACSF)ortwodifferentconcentrationsofZembrin®alkaloidsduringsingle petitive Zembrin® administration. Glutamatergic AMPA receptor
shockstimulation.Statisticalsignificanceofp<0.01ismarkedbystars.
139

## Page 6

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
mediatedneurotransmissionhasbeenknownforalongtime(forreview ThereareseveralpossibilitieshowZembrin®andhisalkaloidsmight
see Seeburg, 1993) and long term potentiation (LTP) as the result of actonAMPA-mediatedtransmission.Zembrin®maydownregulatethe
theta burststimulation has beenshownto be basedmainlyon AMPA expressionofAMPAreceptororinternalizethem.Thereisevidencethat
receptor mediated processes in the hippocampus (Dozmorov et al., the subunit GluR2 of the AMPA receptor interacts with the glyco-
2006).Therefore,thereductionoftheLTPinducedinvivobyrepetitive sphingolipid ganglioside GM1. Gm1 ganglioside prevents seizures
administration of Zembrin® indicates a strong physiological relevance (Figheraetal.,2006).GangliosidessequesterGluR2-containingAMPA
withrespecttoAMPAreceptormediatedtransmission. receptors and GluR2 receptor-trafficing complexes in a reversible AT-
The observation that Zembrin® is able to modulate and shift the Pase-dependent manner that may regulate GluR2-containing AMPAR
excitability of hippocampal activity is in line with pre-clinical and endocytosis, AMPAR ion channel permeability, synaptic plasticity.
clinicalobservations.Spectralanalysisoflocalfieldpotentialsrevealed Learningandmemory.(Prendergastetal.,2014).AttenuationofAMPA
maineffectsonalpha2andbeta1frequenciesespeciallyincorticaland receptor mediated communication within the hippocampus might
hippocampalareas(Dimpfeletal.,2016a).Sincebeta1wavesareunder thereforelead toantiepileptic activity. IntakeofZembrin®maythere-
thecontrolofglutamatergic transmission(Dimpfel,2015)thepresent fore be considered as an add on therapeutical option in patients suf-
results confirm an interference of the action of Zembrin® with this feringfromepilepsy.
transmitter activity. This points to a new mechanism of action in ad-
dition to the two described in an earlier paper, namely inhibition of Acknowledgements
reuptake of serotonin, and inhibition of phosphodiesterase 4 (PDE4)
(Harvey et al., 2011). Whereas the action of Zembrin® on the gluta- Mrs.IngridK.Keplinger-Dimpfelisthankedforperformanceofthe
matergicsystemmightberelatedmoretoaphysiologicalcalmingand logistics of the study and quality control. We greatly appreciate
neuroprotectiveactionleadingtobettercopingwithstress,inhibitionof manuscript reading and correction performed by Mrs. G.N. Chiegoua
serotonin reuptake might point more to a possible anti-depressive ef- Dipah.
fect. Clinical results after intake of Zembrin® indicate a significant
calmingactionand–afterrepetitiveintakeof6weeksduration–alsoan References
anti-anxietyeffect(Dimpfeletal.,2016b,2017).
Asmentionedabove,aconsiderablenumberofalkaloidshavebeen Dimpfel,W.,Spüler,M.,Dalhoff,A.,Hoffmann,W.,Schlüter,G.,1991.Hippocampal
describedforextractsofSceletiumtortuosum,amongthemMesembranol activityinthepresenceofquinolonesandfenbufenin-vitro.Antimicrob.Agents
(Jeffsetal.,1970).Followingthegoalof“reversepharmacology”iso-
Dimp
C
f
h
e
e
l,
m
W
ot
.
h
,
e
D
r
a
.
l
3
h
5
o
,
ff
1
,
1
B
4
.,
2
H
–1
o
1
fm
46
a
.
nn,W.,Schlüter,G.,1994.Electricallyevokedpotentials
lated singleingredientsshouldbe testedinthesame modelandcom- intherathippocampussliceinthepresenceofaminophyllinealoneandincombi-
paredtotheeffectsofthewholeextract.Fourpure(~98%)chemically nationwithquinolones.Eur.Neuropsychopharmacol.4,151–156.
Dimpfel,W.,Hoffmann,J.A.,2011.Effectsofrasagiline,itsmetaboliteaminoindanand
characterizedalkaloidswereavailabletoustobetestedinvitrodirectly
selegilineonglutamatereceptormediatedsignalingintherathippocampusslicein
ontheamplitudeofthepopulationspikeinthepresenceofsingleshock vitro.BMCPharmacol.11,2.http://dx.doi.org/10.1186/1471-2210-11-2.
stimulationaswellasduringthetaburststimulation.Allfouralkaloids Dimpfel,W.,2015.DrugDiscoveryandTranslationalMedicineBasedon
wereabletoattenuatetheamplitudeofthepopulationspikeunderboth NeurophysiologicalTechniques.AholisticapproachtosavinganimalsVerlagBooks
onDemand,Norderstedt,Germany(BoD–BooksonDemandISBN:978-3-7386-
stimulationconditionsinaconcentrationdependentmannersimilarto 7039-4).
theeffectasobservedforthewholeextract(Zembrin®). Meanwhileit Dimpfel,W.,Schombert,L.,Gericke,N.,2016a.Electropharmacogramofsceletiumtor-
hasbeenshownthatallfouralkaloidschangethefrequencypatternof
tuosumextractbasedonspectrallocalfieldpowerinconsciouslyfreelymovingrats.
ratfieldpotentialsataverylowdosageof10µg/kggivenorallyandby
J.Ethnopharmacol.177,140–147.
Dimpfel,W.,Gericke,N.,Suliman,S.,Chigoua-Dipah,G.N.,2016b.Psychophysiological
itproofedtobeabletocrossthebloodbrainbarrier(Dimpfeletal.,to effectsofZembrin®usingquantitativeEEGsourcedensityincombinationwitheye
be published). Mesembrine, Mesembrenone, Mesembrenol and Me-
trackingin60healthysubjects.Neurosci.Med.7,114–132.
Dimpfel,W.,Gericke,N.,Suliman,S.,Chigoua-Dipah,G.N.,2017.EffectofZembrin®on
sembranolmustthereforebeallconsideredtocontributetotheaction
brainelectricalactivityin60oldersubjectsafter6weeksdailyintake.WorldJ.
of Zembrin® to a significant degree and are suitable to be used for Neurosci.7,140–171.
standardization of alkaloid content and composition during the pro- Dingledine,R.,1984.BrainSlices.PlenumPress,NewYork,London.
Dozmorov,M.,Li,R.,Abbas,A.K.,Hellberg,F.,Farre,C.,Huang,F.S.,Jilderos,B.,
ductionofSceletiumextracts.
Wigström,H.,2006.ContributionofAMPAandNMDAreceptorstoearlyandlate
Finallythequestionarosewhich,ifany,ofthefouralkaloidswould phasesofLTPinhippocampalslices.Neurosci.Res.55,182–188.
more selectively act on AMPA-mediated neurotransmission, as shown Fighera,M.R.,Royes,Lf,Furian,A.F.,Oliveira,M.S.,Fiorenza,N.G.,Frussa-Filho,R.,
for the total plant extract. Within a final series of these experiments Petry,J.C.,Coelho,R.C.,Mello,C.F.,2006.GM1gangliosidepreventsseizures,Na
+,K+-ATPaseactivityinhibitionandoxidativestressinducedbyglutaricacidand
each of the four alkaloids was tested to see which would prevent the pentylenetetrazole.Neurobiol.Dis.22,611–623.
action of the AMPA agonist Fluorowillardine. Interestingly, only Gericke,N.,2001.ClinicalapplicationofselectedSouthAfricanmedicinalplants.
Mesembrenol and Mesembranol were able to prevent the action of
Austrlas.J.Med.Herbal.13,3–17.
Gericke,N.,2002.Plants,productsandpeople:SouthernAfricanperspectives.In:Iwu,
Fluorowillardineasobservedforthetotalextract.Therefore,thesetwo M.,Wootton,J.C.(Eds.),EthnomedicineandDrugDiscovery.Elsevier,Amsterdam.
ingredients-beingeffectiveinthenanomolarrange-mustberegarded Gericke,N.,Viljoen,A.M.,2008.Sceletium–Areviewupdate.J.Ethnopharmacol.119,
asthemaincompoundsresponsibleforthephysiologicalcalmingaction
653–663.
ofZembrin®.Presently,itisunclearwhyMesembrenoneinthepresence Haas
o
,
f
H
n
.
e
L
r
.
v
,
o
S
u
ch
s
a
t
e
is
r
s
e
u
r
e
,B
s
.
l
,
ic
V
e
o
s
s
i
m
n
a
v
n
it
s
r
k
o
y
.
,
J
M
.
.
N
,
e
1
u
9
r
7
o
9
s
.
ci
A
.M
sim
et
p
h
l
o
e
d
p
s
e
1
r
,
fu
3
s
2
io
3
n
–3
c
2
h
5
a
.
mberforthestudy
of Fluorowillardine induces a statistically significant increase of the Hartwich,C.,Zwicky,E.,1914.WissenschaftlicheMitteilungen.UeberChanna,ein
populationspikeduringsingleshockstimulation.Itmightwellbe,that GuussmittelderHottentotten(MesembrythanthemumexpansumL.undM.tortuosum
L.).Apoth.-Ztg.94,925–926.
theactivecomponentsremainattachedtotherelevantreceptorsduring
Harvey,A.L.,Young,L.C.,Viljoen,A.M.,Gericke,N.P.,2011.Pharmacologicalactionsof
theperfusionperiod. theSouthAfricanmedicinalandfunctionalfoodplantSceletiumtortuosumandits
Looking now at the chemical formulas of the four alkaloids, both principalalkaloids.J.Ethnopharmacol.137,1124–1129.
Jacobsen,H.,1960.HandbookofSucculentPlants.Vol.III.Mesembryanthemums
(MesembrenolandMesembranol)areverysimilarinhavingahydroxy
(Ficoidaceae).BlandfordPress,London.
group at the position C6, whereas the other two (Mesembrine and Jeffs,P.W.,Hawks,R.L.,Farrier,D.S.,1970.Structuresofthemesembranolsandthe
Mesembrenone) show a carbonyl group at this location. This means, absoluteconfigurationofmesembrineandrelatedalkaloids.J.Am.Chem.Soc.91,
3831–3839.
that we have discovered a new structure activity relationship. Since
Lynch,G.,Schubert,P.,1980.Theuseofin-vitrobrainslicesformultidisciplnarystudies
attenuation of AMPA mediated transmission has been related to suc- ofsynapticfunction.Ann.Rev.Neurosci.3,1–22.
cessful adjunctive treatment of epileptic patients (Steinhoff, 2015), Pappe,L.,1868.FloraeCapensisMedicae,3rded.Prodromus.AnEnumerationofSouth
Mesembrenol and Mesembranol may serve as new chemical leads for AfricanPlantsusedasRemediesbytheColonistsoftheCapeofGoodHope.W.
Brittain,CapeTown.
thedevelopmentofnewdrugsforthetreatmentofepilepsy.
140

## Page 7

W.Dimpfeletal.
Journal of Ethnopharmacology 223 (2018) 135–141
Patnala,S.,Kanfer,I.,2009.InvestigationofthephytochemicalcontentofSceletium Shikanga,E.A.,Viljoen,A.M.,Combrinck,S.,Marston,A.,Gericke,N.,2012.Theche-
tortuosumfollowingpreparationof“Kougoed”byfermentation.J.Ethnopharmacol. motypicvariationofSceletiumtortuosumalkaloidsandcommercialproductfor-
121,86–91. mulations.Biochem.Syst.Ecol.44,364–373.
Prendergast,J.,Umanah,G.K.E.,Yoo,S.-W.,Lagerlöf,O.,Motary,M.G.,Cole,R.N., Smith,M.T.,Crouch,N.R.,Gericke,N.,Hirst,M.,1996.Psychoactiveconstituentsofthe
Huganir,R.L.,Dawson,T.M.,Dawson,V.L.,Schnar,R.L.,2014.Gangliosideregula- genusSceletiumN.E.Br.andotherMesembryanthemaceae:areview.J.
tionofAMPAreceptortrafficking.J.Neurosci.34,13246–13258. Ethnopharmacol.50,119–130.
Seeburg,E.H.,1993.Themolecularbiologyofmammalianglutamatereceptorchannels. Steinhoff,B.J.,2015.TheAMPAreceptorantagonistperampanelintheadjunctive
TrendsNeurosci.16,359–365. treatmentofpartial-onsetseizures:clinicaltrialevidenceandexperience.Ther.Adv.
Schiff,S.J.,Somjen,G.G.,1985.Theeffectsoftemperatureonsynaptictransmissionin Neurol.Disord.8,137–147.
hippocampaltissueslices.BrainRes.345,279–284. VanWyk,B.-E.,Wink,M.,2004.MedicinalPlantsoftheWorld.Briza,Pretoria.
Shannon,R.S.,Minakshi,N.,Ahmad,N.,2007.Dosetranslationfromanimaltohuman Willcox,M.L.,Graz,B.,Falquet,J.,Diakite,C.,Giani,S.,Diallo,D.,2011.A“reverse
studiesrevisited.FASEBJ.22,1–3. pharmacology”approachfordevelopingananti-malarialphytomedicine.Malar.J.
Shikanga,E.A.,Viljoen,A.,Combrinck,S.,Marston,A.,2011.IsolationofSceletiumal- 10,58.http://dx.doi.org/10.1186/1475-2875-10-S1-S8.
kaloidsbyhigh-speedcountercurrentchromatography.Phytochem.Lett.4,190–193.
141

